There continues to be ongoing need for effective therapies in MASLD. This session highlights treatment responses to available and approved therapeutics in MASLD.

Basic science talks that examine mechanisms of hepatic fibrosis and stellate cell biology

This session highlights clinical research advances in metabolic dysfunction-associated steatotic liver disease (MASLD). exploring the role of hepatic steatosis, fibrosis, and inflammation on MASLD.

This scientific session focuses on novel experimental approaches and molecular insights into the pathogenesis of Alcohol-Associated Liver Disease (ALD), exploring potential therapeutic targets for its treatment.